��ѻ��ý

The findings, published in the New England Journal of Medicine, showed that early outpatient treatment using high-titer COVID convalescent plasma reduced the need for hospitalization by more than half.

In most households where both children and adults had antibody evidence of SARS-CoV-2 infection, children ages 0-4 years had the highest levels of SARS-CoV-2 RBD and neutralizing antibodies of all infected household members.    

Even as BA.2 and “deltacron” set off feelings of panic or exhaustion, vaccinations and boosters continue to provide the best protection.

The study findings underscore the importance of prioritizing worker safety and well-being in health departments and in public health systems, especially in times of crisis and discord.

New evidence suggests anyone infected with COVID is at higher risk for heart issues—a risk that persists even in relatively healthy people long after the illness has passed.

Covid shots keep kids out of the hospital and in school—and can prevent serious health issues like long Covid and MISC-C.

Using common strategies to address transmission, testing, and treatment of respiratory viruses will help us keep illnesses in check—and prepare for future pandemics.

The next White House Global COVID-19 Summit is a chance for advocates to push for investments to end the pandemic, including expanding access to existing tools and accelerating innovation.

Cancer treatment and the continuity of care for cancer survivors was disrupted for many Americans during the pandemic, but the African American population was disproportionately affected.

Booster doses helped to avert hospitalizations and severe disease among those who received them—and they are also likely to protect us when the next wave hits.

How parents and families can continue to protect their loved ones as mask mandates are rolled back amid fluctuating COVID rates.

Workplace vaccine requirements are an effective way to protect employee health—and to help pave a path out of the pandemic.

Review of pre-omicron evaluations examining four COVID-19 vaccines finds protection against severe COVID-19 fell by 10 percent on average from one to six months after full vaccination.

When the Ebola virus was ravaging West African countries in 2014, health care providers, public health researchers and activists worked feverishly to stamp it out before it spread and turned into the type of life-shattering pandemic we’re all too familiar with today.